SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043985
Filing Date
2021-08-12
Accepted
2021-08-12 16:16:42
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alna-10q_20210630.htm   iXBRL 10-Q 2571437
2 EX-3.1 AMENDED COI alna-ex31_101.htm EX-3.1 46166
3 EX-31.1 alna-ex311_6.htm EX-31.1 16663
4 EX-31.2 alna-ex312_7.htm EX-31.2 16699
5 EX-32.1 alna-ex321_8.htm EX-32.1 10197
  Complete submission text file 0001564590-21-043985.txt   7202719

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20210630.xsd EX-101.SCH 42247
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20210630_cal.xml EX-101.CAL 38527
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20210630_def.xml EX-101.DEF 179613
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20210630_lab.xml EX-101.LAB 361541
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20210630_pre.xml EX-101.PRE 296087
11 EXTRACTED XBRL INSTANCE DOCUMENT alna-10q_20210630_htm.xml XML 1002492
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 211167797
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences